Replimune (REPL) Net Cash Flow (2017 - 2025)

Replimune has disclosed Net Cash Flow across 9 years of filings, most recently posting $19.6 million for Q4 2025.

• Net Cash Flow for Q4 2025 came in at $19.6 million, down 66.69% year-over-year; the trailing twelve-month figure through Dec 2025 was -$50.8 million (down 167.89% YoY), and the FY2025 annual result was $36.4 million, up 150.5% from the prior year.
• Net Cash Flow came in at $19.6 million for Q4 2025 at Replimune, up from $3.3 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of $117.7 million in Q4 2022 to a low of -$141.6 million in Q1 2021.
• The 5-year median for Net Cash Flow is -$24.4 million (2022), against an average of -$10.2 million.
• Across the five-year window, Net Cash Flow tumbled 4081.16% in 2021 and jumped 523.56% in 2022, its largest moves.
• Replimune's Net Cash Flow stood at -$27.8 million in 2021, then surged by 523.56% to $117.7 million in 2022, then plunged by 81.57% to $21.7 million in 2023, then soared by 171.38% to $58.9 million in 2024, then tumbled by 66.69% to $19.6 million in 2025.
• The last three Net Cash Flow figures came in at $19.6 million (Q4 2025), $3.3 million (Q3 2025), and -$12.1 million (Q2 2025), per Business Quant data.